发明名称 N-(HETERO)ARYL,2-(HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS Wnt SIGNALING MODULATORS
摘要 The present invention relates to N-(hetero)aryl,2-(hetero)aryl-substituted acetamides of structural formulae (1)-(6), where X, X, Xand X, X, X, Xand X, X, Z, m and radicals R-Rare defied in the invention claims. The compounds of the invention have activity for modulating the Wnt signaling pathway and can be used for the treating a Wnt-mediated disorder in a mammal suffering from it. Besides, the invention relates to a pharmaceutical composition for modulating the Wnt signaling pathway and also to methods for inhibiting Wnt signaling in a cell or a Porcupine gene in a cell, and a method for treating many Wnt-mediated disorders. The invention relates to the use of the compound of the invention or a physiologically acceptable salt thereof inhibiting Wnt signaling pathway and also for the manufacture of a medicament for treating a Wnt-mediated disorder.
申请公布号 EA021225(B1) 申请公布日期 2015.05.29
申请号 EA20110001244 申请日期 2010.03.01
申请人 NOVARTIS AG 发明人 CHENG DAI;ZHANG GUOBAO;HAN DONG;GAO WENQI;PAN SHIFENG
分类号 C07D213/75;A61K31/44;A61P35/00;C07D401/12;C07D401/14;C07D403/12;C07D413/14;C07D417/12;C07D417/14 主分类号 C07D213/75
代理机构 代理人
主权项
地址